Chronic Diseases and Translational Medicine (CDTM)

Focused on chronic diseases and related translational research. Indexed in Scopus, PubMed, PMC, Embase, DOAJ. CiteScore 2023: 6.7, Rank #60/636

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🫁✨ New Systematic Review: Durvalumab plus tremelimumab improved survival in metastatic NSCLC with PD-L1 <1%, with fewer treatment-related adverse events than chemotherapy.
🔗https://t.co/LmFZkfKS3D
#LungCancer #NSCLC #Immunotherapy
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧠New Research: Stroke rehabilitation improved physical function, balance, and quality of life, but patients remained below population norms after rehabilitation💪.
🔗https://t.co/NVeh3OYDfw
#Stroke #Rehabilitation #QualityOfLife
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧠 New Research: Severe OSA was linked to higher plasma total Tau and lower MMSE performance, with intermittent hypoxia and sleep fragmentation showing the strongest associations.
🔗https://t.co/nxgdVnhcW1
#SleepApnea #Cognition #Tau
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

💉🔍 New Review: GLP-1 receptor agonists increase retained gastric contents during endoscopy, but aspiration risk remains low. Guidance favors risk-based management over routine drug cessation.
🔗https://t.co/npyjdxFCdK
#GLP1 #Endoscopy #PatientSafety
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🚀New Perspective: Brazil’s adoption of robot-assisted prostatectomy shows how surgical innovation can promote equity and population health🇧🇷🤖.
🔗https://t.co/sk9zrGVrjZ
#RoboticSurgery #ProstateCancer #HealthEquity
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧪✨New Research: Plasma exosome metabolomics revealed stage-specific changes in elderly women with pre-MetS and MetS, highlighting candidate exosomal biomarkers. 💡🩺
🔗https://t.co/VWzPFnIXoq
#MetabolicSyndrome #Exosomes
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

✨New Report: CGM-supported remote monitoring after hospital discharge was feasible, well accepted, and helpful in guiding telehealth glycemic management in higher-risk diabetes populations🏥.
🔗https://t.co/S31OrfdUB0
#Diabetes #CGM #Telehealth
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧬New Research: Single-cell profiling of gastric cancer metastasis identified NAP1L1 as a conserved driver of epithelial reprogramming, alongside distinct immune remodeling.
🔗 https://t.co/nkcJbjXNLo
#GastricCancer #SingleCell #TumorMicroenvironment
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

📊New Research: Multimorbidity increased ADL and IADL disability in older adults in Ireland👵, with earlier IADL impairment and worse functional decline linked to depression and age📉.
🔗https://t.co/Q7bEA0VOQG
#Multimorbidity #Aging #PublicHealth
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧬New Research:Single-cell profiling revealed distinct immune hallmarks in untreated colorectal cancer liver metastases, including enriched CXCL13+ CD4 T cells, Tregs, SPP1+ macrophages, and IGFBP7+ CAFs.
🔗https://t.co/RlgcmwK4nr
#ColorectalCancer #SingleCell
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🫀 New Research: Nearly one-third of Indian adults aged ≥40 had a ≥10% 10-year CVD risk, with alcohol use, hypertension, and social vulnerability linked to higher risk.
🔗https://t.co/dKKunlM8Zs
#CardiovascularRisk #India #PublicHealth
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🔍 New Research: A stacked multi-label model accurately predicted co-occurring microvascular and macrovascular complications in type 2 diabetes, with distinct risk profiles revealed by SHAP analysis.
🔗 https://t.co/5qUadjfHQu
#Type2Diabetes #MachineLearning
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🌏New Perspective: Chronic diseases remain a major public health challenge in Australia, with Tasmania bearing a disproportionate burden shaped by ageing, disadvantage, and modifiable risk factors.
🔗https://t.co/wjdHUF6adR
#ChronicDisease #PublicHealth #Epidemiology
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

💉 New Review: GLP-1 receptor agonists are emerging as dual liver–heart therapies in MASLD, improving steatohepatitis and fibrosis while reducing major cardiovascular events🫀.
🔗https://t.co/hKEWVBvSVk
#MASLD #GLP1 #CardiometabolicHealth
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🫀New Systematic Review: Frailty was linked to cardiovascular events mainly in overweight/obese individuals, suggesting body composition and metabolic profile may shape cardiovascular risk in frailty.
🔗https://t.co/G3lqBKVvIs
#Frailty #CardiovascularDisease #Obesity
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

📰New Report:Adding symptom frequency and severity improved machine-learning accuracy for Long COVID classification, outperforming occurrence-only models and better distinguishing meaningful illness.
🔗https://t.co/pwPg5LTbH4
#LongCOVID #MachineLearning #Epidemiology
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

💊New Review: Anti-obesity pharmacotherapy and multimodal care are reshaping obstructive sleep apnea management by reducing weight, AHI, and cardiometabolic risk.
🔗https://t.co/tEztV5y7Bu
#SleepApnea #Obesity #Pharmacotherapy
@WileyHealth @WileyLifeSci

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧪 New Research: Even within the normal range, lower serum sodium and higher potassium were linked to higher mortality, with inflammation partly explaining these risks.
🔗https://t.co/afvgOT7dzx
#CardiovascularHealth #Epidemiology #Inflammation
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🩸 New Report: Rapid recognition of carfilzomib-induced thrombotic microangiopathy and early eculizumab rescued two relapsed myeloma patients, highlighting prompt complement-targeted intervention.
🔗 https://t.co/iXpPrD7k6E
#Hematology #MultipleMyeloma #Nephrology
@WileyHealth

[Chronic Diseases and Translational Medicine (CDTM) @cdtm4]

🧬Original Research: CD33 promotes angiogenesis and tumor progression through immune–vascular interactions, suggesting a potential biomarker and therapeutic target in cancer🎯.
🔗https://t.co/nY5LmYoL0z
#CancerBiology #Angiogenesis #Immunology
@WileyHealth